A thymidylate synthase ternary complex-specific antibody, FTS, permits functional monitoring of fluoropyrimidines dosing

por Patel, Kalpesh, Yerram, Sashidhar R., Azad, Nilofer A., Kern, Scott E.
Publicado 2012

Proteomics as a Tool for Biomarker Discovery

por Kohn, Elise C., Azad, Nilofer, Annunziata, Christina, Dhamoon, Amit S., Whiteley, Gordon
Publicado 2007

Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer

por Baretti, Marina, Zhu, Qingfeng, Fu, Wei, Meyer, Jeffrey, Wang, Hao, Anders, Robert A., Azad, Nilofer S.
Publicado 2022

Current Surgical Management Strategies for Colorectal Cancer Liver Metastases

por Ivey, Gabriel D., Johnston, Fabian M., Azad, Nilofer S., Christenson, Eric S., Lafaro, Kelly J., Shubert, Christopher R.
Publicado 2022

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

por Boyiadzis, Michael M., Kirkwood, John M., Marshall, John L., Pritchard, Colin C., Azad, Nilofer S., Gulley, James L.
Publicado 2018

Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USA

por Healey, Marcus J., Seal, Brian, Princic, Nicole, Black, Danae, Malangone-Monaco, Elisabetta, Azad, Nilofer S., Smoot, Rory L.
Publicado 2022

Mutational profiling of colorectal cancers with microsatellite instability

por Lin, Elaine I., Tseng, Li-Hui, Gocke, Christopher D., Reil, Stacy, Le, Dung T., Azad, Nilofer S., Eshleman, James R.
Publicado 2015

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity

por Yarchoan, Mark, Mohan, Aditya A., Dennison, Lauren, Vithayathil, Teena, Ruggieri, Amanda, Lesinski, Gregory B., Armstrong, Todd D., Azad, Nilofer S., Jaffee, Elizabeth M.
Publicado 2019

DNA-intercalators Causing Rapid Re-expression of Methylated and Silenced Genes in Cancer Cells

por Hossain, M. Zulfiquer, Healey, Megan A., Lee, Calvin, Poh, Weijie, Yerram, Sashidhar R., Patel, Kalpesh, Azad, Nilofer S., Herman, James G., Kern, Scott E.
Publicado 2013

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

por Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Publicado 2017

High performance methylated DNA markers for detection of colon adenocarcinoma

por Klein Kranenbarg, Romy A. M., Vali, Abdul Hussain, IJzermans, Jan N. M., Pisanic, Thomas R., Wang, Tza-Huei, Azad, Nilofer, Sukumar, Saraswati, Fackler, Mary Jo
Publicado 2021

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017

por Javle, Milind, Lee, Sunyoung, Azad, Nilofer S, Borad, Mitesh J, Kate Kelley, Robin, Sivaraman, Smitha, Teschemaker, Anna, Chopra, Ishveen, Janjan, Nora, Parasuraman, Shreekant, Bekaii-Saab, Tanios S
Publicado 2022

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

por Jia, Angela Y., Narang, Amol, Safar, Bashar, Zaheer, Atif, Murphy, Adrian, Azad, Nilofer S., Gearhart, Susan, Fang, Sandy, Efron, Jonathan, Warczynski, Tam, Hacker-Prietz, Amy, Meyer, Jeffrey
Publicado 2019

A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer

por Baretti, Marina, Murphy, Adrian G., Zahurak, Marianna, Gianino, Nicole, Parkinson, Rose, Walker, Rosalind, Lopez-Vidal, Tamara Y., Zheng, Lei, Rosner, Gary, Ahuja, Nita, Kurt, Schalper, Azad, Nilofer S.
Publicado 2023

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

por Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Parkinson, Rose, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Publicado 2018

Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)

por Viúdez, Antonio, Carvalho, Filipe L.F., Maleki, Zahra, Zahurak, Marianna, Laheru, Daniel, Stark, Alejandro, Azad, Nilofer S., Wolfgang, Christopher L., Baylin, Stephen, Herman, James G., De Jesus-Acosta, Ana
Publicado 2017

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

por Derks, Sarah, Cleven, Arjen H. G., Melotte, Veerle, Smits, Kim M., Brandes, Johann C., Azad, Nilofer, van Criekinge, Wim, de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Publicado 2013

A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)

por Viúdez, Antonio, Carvalho, Filipe L.F., Maleki, Zahra, Zahurak, Marianna, Laheru, Daniel, Stark, Alejandro, Azad, Nilofer Z., Wolfgang, Christopher L., Baylin, Stephen, Herman, James G., De Jesus-Acosta, Ana
Publicado 2016

Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells

por Sharma, Anup, Vatapalli, Rajita, Abdelfatah, Eihab, Wyatt McMahon, K., Kerner, Zachary, A. Guzzetta, Angela, Singh, Jasvinder, Zahnow, Cynthia, B. Baylin, Stephen, Yerram, Sashidhar, Hu, Yue, Azad, Nilofer, Ahuja, Nita
Publicado 2017

Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells

por Sharma, Anup, Vatapalli, Rajita, Abdelfatah, Eihab, McMahon, K. Wyatt, Kerner, Zachary, A. Guzzetta, Angela, Singh, Jasvinder, Zahnow, Cynthia, Baylin, Stephen B., Yerram, Sashidhar, Hu, Yue, Azad, Nilofer, Ahuja, Nita
Publicado 2020